Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 447,179 | 23,383 | 12,672 | -223,812 | -348,101 |
| Depreciation Amortization | -2,328 | -4,709 | 565 | 2,028 | 2,091 |
| Income taxes - deferred | -348,000 | N/A | N/A | N/A | N/A |
| Accounts receivable | -176,443 | -78,092 | -51,093 | 1,389 | -1,389 |
| Other Working Capital | -194,537 | -109,297 | -84,659 | -1,647 | -12,216 |
| Other Operating Activity | 249,357 | 128,198 | 91,102 | 45,872 | 63,981 |
| Operating Cash Flow | $-24,772 | $-40,517 | $-31,413 | $-176,170 | $-295,634 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,263 | 384 | -50,651 | -19,999 | 69 |
| PPE Investments | -214 | -45 | N/A | -14 | -401 |
| Purchase Of Investment | -1,250 | -1,375 | N/A | N/A | N/A |
| Investing Cash Flow | $13,799 | $-1,036 | $-50,651 | $-20,013 | $-332 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 244,815 | 25,000 | N/A | 70,000 |
| Debt Repayment | N/A | -107,553 | N/A | -975 | -30,000 |
| Common Stock Issued | 1,511 | 914 | 47,830 | 584 | 2,435 |
| Common Stock Repurchased | -91,240 | -8,760 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -889 | -125 | 0 | -1,016 |
| Financing Cash Flow | $-89,729 | $128,527 | $72,705 | $-391 | $41,419 |
| Beginning Cash Position | 181,192 | 94,218 | 103,577 | 300,151 | 554,698 |
| End Cash Position | 80,490 | 181,192 | 94,218 | 103,577 | 300,151 |
| Net Cash Flow | $-100,702 | $86,974 | $-9,359 | $-196,574 | $-254,547 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,772 | -40,517 | -31,413 | -176,170 | -295,634 |
| Capital Expenditure | -214 | -45 | N/A | -14 | -401 |
| Free Cash Flow | -24,986 | -40,562 | -31,413 | -176,184 | -296,035 |